FINAL RESULTS OF BIOAVAILABILITY STUDY OF PHEBRA’S ORAL ARSENI...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
SYDNEY, MAY 14 /Medianet International-AsiaNet/ -- Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP433 at the virtual European Hematology Association (EHA) 2021 Conference. The abstract bui...
Authors: LATEST ASIANET NEWS RELEASES